Home   -   Contact Us  

Eric Karran, Ph.D.

Director of Research Strategy at Alzheimer's Research UK

Eric H. Karran PhD is a molecular biochemist by training. Eric is currently the Director of Research for Alzheimer’s Research UK, one of the largest dementia research charities in the world. Eric has responsibility for the organization’s strategic scientific direction. Eric has launched the Drug Discovery Alliance, which places three Drug Discovery Institutes in the Universities of Oxford, Cambridge and University College London, and the Dementia Consortium, a collaboration between the Medical Research Charity-Technology, Eisai Pharmaceuticals and Eli Lilly and Company, to perform validation & lead generation studies on novel targets for neurodegenerative diseases. Eric has spent most of his career in the pharmaceutical industry, leading and managing multi-disciplinary drug discovery teams. He has held senior positions in a number of companies, including SmithKline Beecham (now GSK), Pfizer, Eli Lilly and most recently was Vice President of Neuroscience Discovery at Johnson and Johnson. Eric has specialized in Neuroscience research, particularly Alzheimer’s disease and cognitive impairment, for the past 20 years. During his career Eric has led teams that have put a number of drugs into clinical development. Eric is a Visiting Professor in the Department for Human Genetics at the Catholic University of Leuven, Belgium; an Honorary Senior Research Associate in the Department of Molecular Neuroscience at the Institute of Neurology, University College London; and Visiting Professor of Neurodegenerative Diseases at the University of Lincoln, United Kingdom.